Autologous Gene Editing for Sickle Cell Disease and Transfusion Dependent Beta Thalassemia
-
Register
- Non-member - Free!
- Member - Free!
Already registered?
Log in now.
The Advanced Practice Providers SIG hosted a webinar on 'Autologous Gene Editing for Sickle Cell Disease and Transfusion Dependent Beta Thalassemia' on Thursday, July 18, at 2 p.m. CDT. This webinar is open to all ASTCT members and non-members. Please note that there is no CME offered for attending this webinar.
Speaker:
Haydar Frangoul, MD, MS; Program Director, Sarah Cannon Pediatric Hematology/Oncology & Cellular Therapy @TriStar Centennial
Session Learning Objectives:
- Understand importance of elevated fetal hemoglobin in SCD and TDT
- Review gene editing technology to induce fetal hemoglobin
- Review gene therapy patient journey
- Understand indications for gene editing in SCD and TDT
- Review the updated results for gene therapy
- Understand toxicities related to gene editing therapy
Key:
Complete
Next
Failed
Available
Locked